Avidity Biosciences
RNA
$25.14
Share price
4.06%
Change (1 day)
49.11%
Change (1 year)
Categories
Earnings for Avidity Biosciences (RNA)
Earnings in 2023 (TTM): -$0.22 B
According to Avidity Biosciences's latest financial reports the company's current earnings (TTM) are -$0.22 B. In 2022 the company made an earning of -$0.18 B a decrease over its 2021 earnings that were of -$0.12 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Avidity Biosciences from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$0.22 B | 21.97% |
| 2022 | -$0.18 B | 47.44% |
| 2021 | -$0.12 B | 166.06% |
| 2020 | -$44.36 M | 79.33% |
| 2019 | -$24.74 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $3.26 B | -1,639.44% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $7.53 B | -3,650.57% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | -$0.53 B | 145.07% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$0.7 B | 228.01% | 🇺🇸 USA |
 Fate Therapeutics
FATE | -$0.2 B | -10.23% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.27 B | 24.32% | 🇺🇸 USA |
 Acceleron Pharma XLRN | -$0.26 B | 20.39% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | $94.51 M | -144.53% | 🇺🇸 USA |